Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094120
Filing Date
2024-08-08
Accepted
2024-08-08 16:41:31
Documents
53
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aclx-20240630.htm   iXBRL 10-Q 1817265
2 EX-31.1 aclx-ex31_1.htm EX-31.1 13488
3 EX-31.2 aclx-ex31_2.htm EX-31.2 13491
4 EX-32.1 aclx-ex32_1.htm EX-32.1 7799
5 EX-32.2 aclx-ex32_2.htm EX-32.2 8025
  Complete submission text file 0000950170-24-094120.txt   6037326

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aclx-20240630.xsd EX-101.SCH 1194227
55 EXTRACTED XBRL INSTANCE DOCUMENT aclx-20240630_htm.xml XML 552413
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41259 | Film No.: 241189158
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)